Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

Study ID: NCT06627244
Start Date: 2025-02-14
End Date: 2031-02-17
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Tebentafusp

TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

9-ING-41 in Pediatric Patients with Refractory Malignancies.

Study ID: NCT04239092
Start Date: 2020-06-05
End Date: 2024-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

68

Intervention / Treatment

9-ING-41

Irinotecan

Temozolomide

Cyclophosphamide

Topotecan

Sponsor

Actuate Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

Study ID: NCT05271292
Start Date: 2022-08-26
End Date: 2025-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Chiauranib

Sponsor

Chipscreen Biosciences, Ltd.

Source: clinicaltrials.gov

Share:
Add to list

MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer

Study ID: NCT05903092
Start Date: 2023-09-26
End Date: 2027-01-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

38

Intervention / Treatment

Durvalumab

Monleejumb

Carboplatin or Cisplatin

Etoposide

Sponsor

Hirwa Mandani

Source: clinicaltrials.gov

Share:
Add to list

Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants

Study ID: NCT06566092
Start Date: 2024-03-28
End Date: 2028-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

LN-145 / LN-144

Sponsor

Iovance Biotherapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

Study ID: NCT05226494
Start Date: 2022-06-23
End Date: 2025-10-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

34

Intervention / Treatment

fb-PMT

Sponsor

NanoPharmaceuticals LLC

Source: clinicaltrials.gov

Share:
Add to list

Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer

Study ID: NCT05959291
Start Date: 2023-07-17
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Discontinuation of Anti-HER-2 Maintenance Treatment

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Study ID: NCT05789394
Start Date: 2023-06-16
End Date: 2025-07-24
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Allogeneic Adipose-derived Mesenchymal Stem Cells

Biospecimen Collection

Craniotomy

Magnetic Resonance Imaging

Ommaya Reservoir Tap

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer

Study ID: NCT04134260
Start Date: 2020-03-05
End Date: 2026-11-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

586

Intervention / Treatment

Apalutami

Hormone Therapy

Quality-of-Life Assessment

Administration questionnaire

Radiation Therapy

Sponsor

NRG Oncology

Source: clinicaltrials.gov

Share:
Add to list

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

Study ID: NCT06252662
Start Date: 2024-10-15
End Date: 2025-10
Study Type

Interventional

Study Phase

Phase4

No. of Participants

200

Intervention / Treatment

Dexmedetomidine

Liposomal bupivacaine

Sponsor

United States Naval Medical Center, Portsmouth

Source: clinicaltrials.gov

Share:
Add to list